Monday, June 29, 2020

Gilead Prices COVID-19 Drug At $2,340 Per Patient In Developed Nations

Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the...

from NDTV News - Latest https://ift.tt/3dKZIH5
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Newly Crowned Miss North Carolina USA Dethroned After Alleged Racist Posts Resurface

While organisers did not specify the content of the posts, they said the pageant must uphold the standards expected of its titleholders. f...